State legislatures in New York and New Jersey are advancing several health policy measures this week, while New Hampshire is hosting a commission meeting on addiction. In New York, the Senate Rules Committee received two bills: S10718, sponsored by Senator William Weber to improve residential care for Prader-Willi syndrome, and S10720, sponsored by Senator Rachel May to create an educational module on tickborne illnesses. New Jersey lawmakers introduced S4793 to mandate a preferred drug list for the state Medicaid program and S4825, which directs the Department of Health to assess the volunteer emergency medical services workforce. Additionally, the New Hampshire State House scheduled an event for the Governor's Commission on Addiction, Treatment and Prevention on October 9, 2026. These actions reflect ongoing efforts to standardize drug procurement, evaluate emergency service capacity, and address specific medical conditions through state-level oversight. Synthesized from 7 manifests produced by 4 sources across the 50 monitored statehouse streams in the last 7 days, including health bills, public-health measures.
Answer updated Oct 13, 2026 12:00 UTC · rebuilt twice daily from the rolling 168-hour window
New York S10718 referred to Senate Rules Committee on October 7, 2026
New York Senate bill S10718, sponsored by Senator William Weber, proposes the "Prader-Willi syndrome residential stabilization and best-practice support act." The legislation seeks to improve residential care and support services for individuals diagnosed with Prader-Willi syndrome. The bill is currently pending in the
New York S10720 referred to Senate Rules Committee
New York Senate bill S10720, sponsored by Senator Rachel May, seeks to establish a state-wide educational module regarding tickborne illnesses. The proposed curriculum targets medical colleges, universities, county health departments, and the general public. The bill is currently pending in the Senate Rules Committee f
New Jersey S4793 establishes and requires use of Medicaid preferred drug list
The New Jersey Legislature has introduced S4793, a bill that mandates the creation and utilization of a preferred drug list for the state's Medicaid program. This measure aims to standardize medication coverage and potentially influence drug procurement costs within the state healthcare system. The bill's status as of
New Jersey S4825: Requires DOH to report on volunteer EMS workforce and capacity
New Jersey S4825 directs the Department of Health to conduct a comprehensive assessment of the state's volunteer emergency medical services. The measure requires the collection and analysis of data concerning workforce size, operational capacity, and service reliability. This legislative action seeks to provide a clear
THE GOVERNOR'S COMMISSION ON ADDICTION, TREATMENT AND PREVENTION: NH State House Event